Piramal Pharma Solutions is a global leader in antibody-drug conjugate (ADC) development and manufacturing, leveraging over ...
In part 1 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, explains the difference ...
Pharmaceutical Technology on MSN
Nucleai and Sirona Dx to provide new proteomics solution for pharma companies
Under the partnership, Sirona Dx oversees assay design, development and validation, ensuring quality image production.
Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO, specialized in spatial biology and single-cell services, today announced a strategic partnership to deliver a ...
Some disease areas bucked the trend of shrinking pipelines, however, with immune and cardiovascular indications seeing an ...
Senhwa Biosciences raises $16M to advance AI-powered drug discovery, accelerate cancer treatment trials, and expand machine ...
Partnerships in healthcare have never been more important. Through collaboration, industry specialists are increasingly bringing cutting-edge medical innovations and life-changing treatments to ...
Pharmaceutical Technology on MSN
Pharma 5.0, sustainability & security: PHARMAP 2026 brings pharma’s future into focus
As the pharmaceutical industry navigates a series of interconnected industry challenges, the pharma community’s attention ...
Fierce Biotech has released its annual ranking of the top 10 pharma R&D budgets of 2025—offering a clear look at which ...
The OpenAI partnership is a credible productivity catalyst across discovery, manufacturing, and commercial ops, directly ...
Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results